Nilotinib ameliorates lipopolysaccharide-induced acute lung injury in rats

Toxicology and Applied Pharmacology

Volumn 253, Issue 2, 2011, Pages 153-160

  El Agamy, Dina S ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Acute lung injury; Lipopolysaccharide; Nilotinib; Rats

Indexed keywords

CYTOKINE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NILOTINIB; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; INFLAMMATORY CELL; LUNG EDEMA; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MICROSCOPY; NONHUMAN; PROTEIN CONTENT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; LIPOPOLYSACCHARIDES; LUNG; MALE; NITRATES; NITRITES; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79955610378     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.03.023     Document Type: Article

References (41)

1. Abraham E. Neutrophils and acute lung injury. Crit. Care Med. 2003, 31:S195-S199.
2. Akhmetshina A., Dees C., Pileckyte M., Maurer B., Axmann R., Jüngel A., Zwerina J., Gay S., Schett G., Distler O., Distler J.H. Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J. 2008, 22:2214-2222.
3. Bhattacharyya J., Biswas S., Datta A.G. Mode of action of endotoxin: role of free radicals and antioxidants. Curr. Med. Chem. 2004, 11:359-368.
4. Bhavsar T.M., Cantor J.O., Patel S.N., Lau-Cam C.A. Attenuating effect of taurine on lipopolysaccharide-induced acute lung injury in hamsters. Pharmacol. Res. 2009, 60:418-428.
5. Birukova A.A., Birukov K.G., Adyshev D., Usatyuk P., Natarajan V., Garcia J.G., Verin A.D. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction. J. Cell. Physiol. 2005, 204:934-937.
6. Breccia M., Alimena G. Nilotinib: a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia. Leuk. Res. 2010, 34:129-134.
7. Brigham K.L. Mechanisms of lung injury. Clin. Chest Med. 1982, 3:9-24.
8. Chen Z., Zhang X., Chu X., Zhang X., Song K., Jiang Y., Yu L., Deng X. Preventive effects of valnemulin on lipopolysaccharide- induced acute lung injury. Inflammation 2010, 33:306-314.
9. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 1999, 274:10689-10692.
10. Day E., Waters B., Spiegel K., Alnadaf T., Manley P.W., Buchdunger E., Walker C., Jarai G. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. Eur. J. Pharmacol. 2008, 599:44-53.
11. Del Rio D., Stewart A.J., Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. 2005, 15:316-328.
12. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
13. Ermert M., Ruppert C., Günther A., Duncker H.R., Seeger W., Ermert L. Cell-specific nitric oxide synthase-isoenzyme expression and regulation in response to endotoxin in intact rat lungs. Lab. Invest. 2002, 82:425-441.
14. Fahy R.J., Lichtenberger F., McKeegan C.B., Nuovo G.J., Marsh C.B., Wewers M.D. The acute respiratory distress syndrome: a role for transforming growth factor-ß1. Am. J. Respir. Cell Mol. Biol. 2003, 28:499-503.
15. Giebelen I.A., van Westerloo D.J., LaRosa G.J., de Vos A.F., van der Poll T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 2007, 28:700-703.
16. Goode H.F., Webster N.R. Free radicals and antioxidants in sepsis. Crit. Care Med. 1993, 21:1770-1776.
17. Goodman R.B., Strieter R.M., Martin D.P., Steinberg K.P., Milberg J.A., Maunder R.J., Kunkel S.L., Walz A., Hudson L.D., Martin T.R. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1996, 154:602-611.
18. Janardhan K.S., McIsaac M., Fowlie J., Shrivastav A., Caldwell S., Sharma R.K., Singh B. Toll like receptor-4 expression in lipopolysaccharide induced lung inflammation. Histol. Histopathol. 2006, 21:687-696.
19. Kantarjian H., Giles F., Wunderle L., Bhalla K., O'Brien S., Wassmann B., Tanaka C., Manley P., Rae P., Mietlowski W., Bochinski K., Hochhaus A., Griffin J.D., Hoelzer D., Albitar M., Dugan M., Cortes J., Alland L., Ottmann O.G. Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL. N. Engl. J. Med. 2006, 354:2542-2551.
20. Kinnula V.L., Crapo J.D. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 2003, 167:1600-1619.
21. Macdonald J., Galley H.F., Webster N.R. Oxidative stress and gene expression in sepsis. Br. J. Anaesth. 2003, 90:221-232.
22. Manley P.W., Drueckes P., Fendrich G., Furet P., Liebetanz J., Martiny-Baron G., Mestan J., Trappe J., Wartmann M., Fabbro D. Extended kinase profile and properties of the protein kinase inhibitor nilotinib. Biochim. Biophys. Acta 2010, 1804:445-453.
23. Misra H.P., Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
24. Numata M., Suzuki S., Miyazawa N., Miyashita A., Nagashima Y., Inoue S., Kaneko T., Okubo T. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J. Immunol. 1998, 160:3031-3037.
25. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
26. Piantadosi C.A., Schwartz D.A. The acute respiratory distress syndrome. Ann. Intern. Med. 2004, 141:460-470.
27. Repine J.E., Parsons P.E. Oxidant-antioxidant balance in endotoxin-induced oxidative injury and tolerance to oxidative injury. Endotoxin and the Lungs 1994, 207-227. Marcel Dekker, New York. K.L. Brigham (Ed.).
28. Seki H., Tasaka S., Fukunaga K., Shiraishi Y., Moriyama K., Miyamoto K., Nakano Y., Matsunaga N., Takashima K., Matsumoto T., Ii M., Ishizaka A., Takeda J. Effect of toll-like receptor 4 inhibitor on LPS-induced lung injury. Inflamm. Res. 2010, 59:837-845.
29. Shenkar R., Coulson W.F., Abraham E. Anti-TGF-b1 monoclonal antibodies prevent lung injury in hemorrhaged mice. Am. J. Respir. Cell Mol. Biol. 1994, 11:351-357.
30. Shi J.R., Mao L.G., Jiang R.A., Qian Y., Tang H.F., Chen J.Q. Monoammonium glycyrrhizinate inhibited the inflammation of LPS-induced acute lung injury in mice. Int. Immunopharmacol. 2010, 10:1235-1241.
31. Suntres Z.E., Shek P.N. Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol liposomes. Crit. Care Med. 1998, 26:723-729.
32. Szarka R.J., Wang N., Gordon L., Nation P.N., Smith R.H. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J. Immunol. Methods 1997, 202:49-57.
33. Togbe D., Schnyder-Candrian S., Schnyder B., Doz E., Noulin N., Janot L., Secher T., Gasse P., Lima C., Coelho F.R., Vasseur V., Erard F., Ryffel B., Couillin I., Moser R. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int. J. Exp. Pathol. 2007, 88:387-391.
34. Van Dervort A.L., Yan L., Madara P.J., Cobb J.P., Wesley R.A., Corriveau C.C., Tropea M.M., Danner R.L. Nitric oxide regulates endotoxin-induced TNF-385 alpha production by human neutrophils. J. Immunol. 1994, 152:4102-4109.
35. Vliet V.A., Cross C.E. Oxidants, nitrosants, and the lung. Am. J. Med. 2000, 109:398-421.
36. Wang L.F., Mehta S., Weicker S., Scott J.A., Joseph M., Razavi H.M., McCormack D.G. Relative contribution of hemopoietic and pulmonary parenchymal cells to lung inducible nitric oxide synthase (iNOS) activity in murine endotoxemia. Biochem. Biophys. Res. Commun. 2001, 283:694-699.
37. Wesselkamper S.C., Case L.M., Henning L.N., Borchers M.T., Tichelaar J.W., Mason J.M., Dragin N., Medvedovic M., Sartor M.A., Tomlinson C.R., Leikauf G.D. Gene expression changes during the development of acute lung injury: role of transforming growth factor-b. Am. J. Respir. Crit. Care Med. 2005, 172:1399-1411.
38. Wolf A.M., Wolf D., Rumpold H., Ludwiczek S., Enrich B., Gastl G., Weiss G., Tilg H. The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc. Natl Acad. Sci. U. S. A. 2005, 102:13622-13627.
39. Worthen G.S., Downey G.P. Mechanisms of neutrophil mediated injury. ARDS: Acute Respiratory Distress in Adults 1996, 99-114. Chapman and Hall, London. T.W. Evans, C. Haslett (Eds.).
40. Wu Y., Singer M., Thouron F., Alaoui-El-Azher M., Touqui L. Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L743-L750.
41. Zinetti M., Fantuzzi G., Delgado R., Di Santi E., Ghezzi P., Fratelli M. Endogenous nitric oxide production by human monocytic cells regulates LPS-induced TNF production. Eur. Cytokine Netw. 1995, 6:45-48.